The DEK Nuclear Autoantigen Is a Secreted Chemotactic Factor

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Molecular and Cellular Biology

• Publication date

  2006-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/MCB.01030-06PMID 17030615PMCID PMC1698538
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intron Removal Requires Proofreading of U2AF/3' Splice Site Recognition by DEK

  2006cited by this paper
• Negative Regulation of the RelA/p65 Transactivation Function by the Product of the DEK Proto-oncogene*

  2006cited by this paper
• Expression analysis of 6p22 genomic gain in retinoblastoma

  2006cited by this paper
• Silver staining of proteins in polyacrylamide gels

  2006cited by this paper
• Exosomes biological significance: A concise review.

  2006cited by this paper
• p300/CBP-associated Factor Drives DEK into Interchromatin Granule Clusters*

  2005cited by this paper
• Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma

  2005cited by this paper
• Differential gene‐expression profiling in the leukemia cell lines derived from indolent and aggressive phases of CD56+ T‐cell large granular lymphocyte leukemia

  2004cited by this paper
• Functional Domains of the Ubiquitous Chromatin Protein DEK

  2004cited by this paper
• Exosomes: endosomal-derived vesicles shipping extracellular messages.

  2004cited by this paper
• The protein kinase CK2 facilitates repair of chromosomal DNA single-strand breaks.

  2004cited by this paper
• Defining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reaction.

  2004cited by this paper
• The DEK protein--an abundant and ubiquitous constituent of mammalian chromatin.

  2004cited by this paper
• Phosphorylation by Protein Kinase CK2 Changes the DNA Binding Properties of the Human Chromatin Protein DEK

  2004cited by this paper
• Cells release prions in association with exosomes.

  2004cited by this paper
• Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion

  2003cited by this paper
• IFN-γ Induces High Mobility Group Box 1 Protein Release Partly Through a TNF-Dependent Mechanism1

  2003cited by this paper
• IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism.

  2003cited by this paper
• Vimentin is secreted by activated macrophages

  2003cited by this paper
• DEK binding to class II MHC Y-box sequences is gene- and allele-specific

  2003cited by this paper
• Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek.

  2002cited by this paper
• Overexpression of translocation-associated fusion genes of FGFRI, MYC, NPMI, and DEK, but absence of the translocations in acute myeloid leukemia. A microarray analysis.

  2002cited by this paper
• Unique Activation Mechanism of Protein Kinase CK2

  2002cited by this paper
• Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T cells.

  2002cited by this paper
• High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis.

  2002cited by this paper
• The Ubiquitous Chromatin Protein DEK Alters the Structure of DNA by Introducing Positive Supercoils*

  2002cited by this paper
• The nuclear protein HMGB1 is secreted by monocytes via a non‐classical, vesicle‐mediated secretory pathway

  2002cited by this paper
• Toward the rational design of protein kinase casein kinase-2 inhibitors.

  2002cited by this paper
• Unique Activation Mechanism of Protein Kinase CK2 THE N-TERMINAL SEGMENT IS ESSENTIAL FOR CONSTITUTIVE ACTIVITY OF THE CATALYTIC SUBUNIT BUT NOT OF THE HOLOENZYME*

  2002cited by this paper
• Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8

  2001cited by this paper
• Protein Phosphatase 2A Activates the HIV-2 Promoter through Enhancer Elements That Include the pets Site*

  2001cited by this paper
• Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

  2001cited by this paper
• HMG‐1 REDISCOVERED AS A CYTOKINE

  2001cited by this paper
• GLI-2 Modulates Retroviral Gene Expression

  2001cited by this paper
• Selectivity of 4,5,6,7‐tetrabromobenzotriazole, an ATP site‐directed inhibitor of protein kinase CK2 (‘casein kinase‐2’)

  2001cited by this paper
• Proteomic Analysis of Dendritic Cell-Derived Exosomes: A Secreted Subcellular Compartment Distinct from Apoptotic Vesicles1

  2001cited by this paper
• The spliceosome deposits multiple proteins 20–24 nucleotides upstream of mRNA exon–exon junctions

  2000cited by this paper
• The identification of novel therapeutic targets for the treatment of malignant brain tumors.

  2000cited by this paper
• The protein encoded by the proto-oncogene DEK changes the topology of chromatin and reduces the efficiency of DNA replication in a chromatin-specific manner.

  2000cited by this paper
• Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugs

  2000cited by this paper
• The Acute Myeloid Leukemia-Associated Protein, Dek, Forms a Splicing-Dependent Interaction with Exon-Product Complexes

  2000cited by this paper
• Regulation of Elastinolytic Cysteine Proteinase Activity in Normal and Cathepsin K–Deficient Human Macrophages

  2000cited by this paper
• Receptor‐binding conformation of the “ELR” motif of IL‐8: X‐ray structure of the L5C/H33C variant at 2.35 Å resolution

  2000cited by this paper
• High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes

  2000cited by this paper
• TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression.

  1999cited by this paper
• Molecular Characterization of Dendritic Cell-Derived Exosomes

  1999cited by this paper
• HMG-1 as a late mediator of endotoxin lethality in mice.

  1999cited by this paper
• Regulated Secretion from Hemopoietic Cells

  1999cited by this paper
• Identification and characterization of genes associated with human hepatocellular carcinogenesis.

  1999cited by this paper
• Autoantibodies to DEK oncoprotein in a patient with systemic lupus erythematosus and sarcoidosis.

  1998cited by this paper
• Species-specificity in endoplasmic reticulum signal peptide utilization revealed by proteins from Trypanosoma brucei and Leishmania.

  1998cited by this paper
• Selective Enrichment of Tetraspan Proteins on the Internal Vesicles of Multivesicular Endosomes and on Exosomes Secreted by Human B-lymphocytes*

  1998cited by this paper
• Interferon‐γ maintains the binding and functional capacity of receptors for IL‐8 on cultured human T cells

  1998cited by this paper
• Identification of a Potent, Selective Non-peptide CXCR2 Antagonist That Inhibits Interleukin-8-induced Neutrophil Migration*

  1998cited by this paper
• DEK, an autoantigen involved in a chromosomal translocation in acute myelogenous leukemia, binds to the HIV-2 enhancer.

  1997cited by this paper
• Antibodies to the 45 kDa DEK nuclear antigen in pauciarticular onset juvenile rheumatoid arthritis and iridocyclitis: selective association with MHC gene.

  1997cited by this paper
• Plasma membrane targetting, vesicular budding and release of galectin 3 from the cytoplasm of mammalian cells during secretion.

  1997cited by this paper
• B lymphocytes secrete antigen-presenting vesicles

  1996cited by this paper
• Synovial fluid interleukin-8 and neutrophil function in rheumatoid arthritis and seronegative polyarthritis.

  1996cited by this paper
• Purification of the pets Factor

  1996cited by this paper
• Migratory responses of PMN after intraperitoneal and intratracheal administration of lipopolysaccharide.

  1996cited by this paper
• Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages.

  1995cited by this paper
• The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*)

  1995cited by this paper
• Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements.

  1995cited by this paper
• A novel autoantibody to the putative oncoprotein DEK in pauciarticular onset juvenile rheumatoid arthritis.

  1994cited by this paper
• The putative oncoprotein DEK, part of a chimera protein associated with acute myeloid leukaemia, is an autoantigen in juvenile rheumatoid arthritis

  1993cited by this paper
• Interleukin-8 (IL-8) in synovial fluid of rheumatoid and nonrheumatoid joint effusions

  1993cited by this paper
• Characterization of the translocation breakpoint sequences of two DEK‐CAN fusion genes present in t(6;9) acute myeloid leukemia and a SET‐CAN fusion gene found in a case of acute undifferentiated leukemia

  1992cited by this paper
• The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA

  1992cited by this paper
• Translocation t(6;9) in acute non-lymphocytic leukaemia results in the formation of a DEK-CAN fusion gene.

  1992cited by this paper
• Antinuclear antibody profile in juvenile rheumatoid arthritis.

  1991cited by this paper
• Presence of NAP‐1/IL‐8 in Synovial Fluids Indicates a Possible Pathogenic Role in Rheumatoid Arthritis

  1991cited by this paper
• Antinuclear antibody in juvenile rheumatoid arthritis sera reacts with 50-40 kDa antigen(s) found in HeLa nuclear extracts.

  1989cited by this paper
• Van Damme A.

  1986cited by this paper
• Silver staining of proteins in polyacrylamide gels.

  1981cited by this paper

• The Integration of Bioinformatics with Experimental Validation Has Uncovered Shared Molecular Characteristics Between Sarcopenia and Osteoarthritis

  2026cites this paper
• Novel perspectives on extracellular vesicles in autoimmune diseases: immunogenicity, inflammation, and immune surveillance

  2026cites this paper
• Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells

  2025cites this paper
• NUP214 in Acute Myeloid Leukemia

  2025cites this paper
• Glutamate utilization fuels rapid production of mitochondrial ROS in dendritic cells and drives systemic inflammation during tularemia

  2025cites this paper
• Emerging Landscape of Supercharged Proteins and Peptides for Drug Delivery.

  2024cites this paper
• DEK deficiency suppresses mitophagy to protect against house dust mite-induced asthma

  2024cites this paper
• Hsa_circ_0001479 accelerates tumorigenesis of gastric cancer and mediates immune escape.

  2023cites this paper
• PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction

  2023influential citation
• NETosis Induced by Serum of Patients with COVID-19 is Reduced with Reparixin or Antibodies Against DEK and IL-8

  2023cites this paper
• One more step toward treatment of PARP inhibitor-resistant ovarian cancers

  2023cites this paper
• A multi‐omic approach identifies an autism spectrum disorder (ASD) regulatory complex of functional epimutations in placentas from children born preterm

  2023cites this paper
• MicroRNA-489-3p attenuates neuropathic allodynia by regulating oncoprotein DEK/TET1-dependent epigenetic modification in the dorsal horn.

  2022cites this paper
• DEK, a nuclear protein, is chemotactic for hematopoietic stem/progenitor cells acting through CXCR2 and Gαi signaling

  2022cites this paper
• Nucleic Acids for Potential Treatment of Rheumatoid Arthritis.

  2022cites this paper
• miR-181-5p attenuates neutrophilic inflammation in asthma by targeting DEK.

  2022cites this paper
• In silico gene expression and pathway analysis of DEK in the human brain across the lifespan

  2022cites this paper
• Proteomic alterations in extracellular vesicles induced by oncogenic PIK3CA mutations

  2022cites this paper
• Doxorubicin induces prolonged DNA damage signal in cells overexpressing DEK isoform-2

  2022cites this paper
• Exosomal DEK removes chemoradiotherapy resistance by triggering quiescence exit of breast cancer stem cells

  2022cites this paper
• Bacterial Growth Inhibition Screen (BGIS) identifies a loss‐of‐function mutant of the DEK oncogene, indicating DNA modulating activities of DEK in chromatin

  2021cites this paper
• Multilocus sequence typing (MLST) of Entamoeba histolytica identifies kerp2 as a genetic marker associated with disease outcomes.

  2021cites this paper
• Nuclear DEK preserves hematopoietic stem cells potential via NCoR1/HDAC3-Akt1/2-mTOR axis

  2021cites this paper
• Circulating extracellular vesicles and rheumatoid arthritis: a proteomic analysis

  2021cites this paper
• DEK Expression in Breast Cancer Cells Leads to the Alternative Activation of Tumor Associated Macrophages

  2020cites this paper
• The functional role of surface molecules on extracellular vesicles in cancer, autoimmune diseases, and coagulopathy

  2020cites this paper
• Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling.

  2019cites this paper
• Analysis of the effect of DEK overexpression on the survival and proliferation of bone marrow stromal cells

  2019cites this paper
• All hands on DEK.

  2019cites this paper
• Citrullinated Inhibitor of DNA Binding 1 Is a Novel Autoantigen in Rheumatoid Arthritis

  2019cites this paper
• DEK Is a Potential Biomarker Associated with Malignant Phenotype in Gastric Cancer Tissues and Plasma

  2019cites this paper
• Extracellular HMGA1 Promotes Tumor Invasion and Metastasis in Triple-Negative Breast Cancer

  2018cites this paper
• High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti–Tumor Necrosis Factor Therapy

  2018influential citation
• A specific phosphorylation regulates the protective role of αA-crystallin in diabetes.

  2018cites this paper
• Rhinovirus infection induces distinct transcriptome profiles in polarized human macrophages.

  2018cites this paper
• Role of extracellular vesicles in rheumatoid arthritis

  2018cites this paper
• The Neutrophil’s Choice: Phagocytose vs Make Neutrophil Extracellular Traps

  2018cites this paper
• Mapping macrophage polarization over the myocardial infarction time continuum

  2018cites this paper
• A role for intracellular and extracellular DEK in regulating hematopoiesis

  2017cites this paper
• DEK associates with tumor stage and outcome in HPV16 positive oropharyngeal squamous cell carcinoma

  2017cites this paper
• Candida albicans Modifies the Protein Composition and Size Distribution of THP-1 Macrophage-Derived Extracellular Vesicles.

  2017cites this paper
• Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case–Control Study of Patients with Head and Neck Squamous Cell Carcinoma

  2017cites this paper
• DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis

  2017cites this paper
• oncogene expression during normal hematopoiesis and in Acute Myeloid Leukemia ( AML ) ☆

  2017cites this paper
• Promotion of cell proliferation by the proto‐oncogene DEK enhances oral squamous cell carcinogenesis through field cancerization

  2017cites this paper
• Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis

  2016influential citation
• New oncogenic networks regulated by the RNA binding factor CUGBP1 in melanoma

  2016cites this paper
• Extracellular vesicles — new tool for joint repair and regeneration

  2016cites this paper
• The chromatin architectural protein DEK : assessing its chromatin binding properties

  2016cites this paper
• Targeting the DEK oncogene in head and neck squamous cell carcinoma: functional and transcriptional consequences

  2015cites this paper
• Dissecting the Potential Interplay of DEK Functions in Inflammation and Cancer

  2015influential citation
• DEK oncogene expression during normal hematopoiesis and in Acute Myeloid Leukemia (AML).

  2015cites this paper
• IRAK1 is a novel DEK transcriptional target and is essential for head and neck cancer cell survival

  2015cites this paper
• The DEK oncoprotein and its emerging roles in gene regulation

  2015cites this paper
• Genetic background of juvenile idiopathic arthritis

  2014cites this paper
• The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor positive breast cancers

  2014cites this paper
• The human oncoprotein and chromatin architectural factor DEK counteracts DNA replication stress

  2014cites this paper
• AWARD NUMBER: W81XWH-12-1-0195 TITLE: Targeting the Ron-DEK Signaling Axis in Breast Cancer PRINCIPAL INVESTIGATORS:

  2014cites this paper
• Harnessing the exosome-induced immune response for cancer immunotherapy.

  2014cites this paper
• Negative regulation of peroxiredoxin 6 (Prdx 6) transcription by nuclear oncoprotein DEK during leukemia cell differentiation

  2014cites this paper
• AWARD NUMBER: W81XWH-12-1-0194 TITLE: Targeting the Ron-DEK Signaling Axis in Breast Cancer PRINCIPAL INVESTIGATORS: Dr. Susanne Wells CONTRACTING ORGANIZATION: Childrens Hospital Cincinnati

  2014cites this paper
• Concise Review: Role of DEK in Stem/Progenitor Cell Biology

  2013cites this paper
• Stacking the DEK: From chromatin topology to cancer stem cells

  2013cites this paper
• Transfer of extracellular vesicles during immune cell‐cell interactions

  2013cites this paper
• Intercellular trafficking of the nuclear oncoprotein DEK

  2013cites this paper
• Immunosuppressive Exosomes: A New Approach for Treating Arthritis

  2012cites this paper
• The DEK Oncogene Is a Target of Steroid Hormone Receptor Signaling in Breast Cancer

  2012cites this paper
• Serological Analysis of SEREX-Defined Medullary Breast Carcinoma-Associated Antigens

  2012cites this paper
• Expression level of DEK in chronic lymphocytic leukemia is regulated by fludarabine and Nutlin-3 depending on p53 status

  2012cites this paper
• Future directions and treatment strategies for head and neck squamous cell carcinomas.

  2012cites this paper
• DEK overexpression is correlated with the clinical features of breast cancer

  2012cites this paper
• Enhancing engraftment of cord blood cells via insight into the biology of stem/progenitor cell function

  2012cites this paper
• Exosomes - the future of vaccination?

  2011cites this paper
• DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen.

  2011cites this paper
• A class of human proteins that deliver functional proteins into mammalian cells in vitro and in vivo.

  2011cites this paper
• Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer

  2011cites this paper
• Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity.

  2011cites this paper
• The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrity.

  2011cites this paper
• DEK expression in melanocytic lesions.

  2011cites this paper
• DEK Regulates Hematopoietic Stem Engraftment and Progenitor Cell Proliferation

  2011cites this paper
• Sub-Nuclear Localization and Tumorigenic Function of the Oncoprotein Dek.

  2010cites this paper
• Exosomes from human macrophages and dendritic cells contain enzymes for leukotriene biosynthesis and promote granulocyte migration.

  2010cites this paper
• αB-Crystallin Is Found in Detergent-resistant Membrane Microdomains and Is Secreted via Exosomes from Human Retinal Pigment Epithelial Cells*

  2010cites this paper
• The Oncogene DEK Promotes Leukemic Cell Survival and Is Downregulated by both Nutlin-3 and Chlorambucil in B-Chronic Lymphocytic Leukemic Cells

  2010cites this paper
• Control of Tumorigenesis and Chemoresistance by the DEK Oncogene

  2010cites this paper
• High-affinity interaction of poly(ADP-ribose) and the human DEK oncoprotein depends upon chain length.

  2010cites this paper
• Leukocytic promotion of prostate cellular proliferation

  2010cites this paper
• Melanoma proliferation and chemoresistance controlled by the DEK oncogene.

  2009cites this paper
• Clinicopathological significance of DEK overexpression in serous ovarian tumors

  2009cites this paper
• Progress in studies on the DEK protein and its involvement in cellular apoptosis

  2009cites this paper
• The Somatostatin 2A Receptor Is Enriched in Migrating Neurons during Rat and Human Brain Development and Stimulates Migration and Axonal Outgrowth

  2009cites this paper
• DEK oncoprotein is a novel regulator of NF-κB transactivation and DNA damage-induced apoptosis.

  2009cites this paper
• Protein kinase CK2 in human diseases.

  2008cites this paper
• Role of HMGB1 in cells of the circulation

  2008cites this paper
• DEK Is a Poly(ADP-Ribose) Acceptor in Apoptosis and Mediates Resistance to Genotoxic Stress

  2008influential citation